Outcomes in Newly Diagnosed Elderly Glioblastoma Patients after Concomitant Temozolomide Administration and Hypofractionated Radiotherapy

This study aimed to analyze the treatment and outcomes of older glioblastoma patients. Forty-four patients older than 70 years of age were referred to the Paul Strauss Center for chemotherapy and radiotherapy. The median age was 75.5 years old (range: 70–84), and the patients included 18 females and...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Ludovic T., Touch, Socheat, Nehme-Schuster, Hélène, Antoni, Delphine, Eav, Sokha, Clavier, Jean-Baptiste, Bauer, Nicolas, Vigneron, Céline, Schott, Roland, Kehrli, Pierre, Noël, Georges
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3795385/
https://www.ncbi.nlm.nih.gov/pubmed/24202340
http://dx.doi.org/10.3390/cancers5031177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3795385/
https://www.ncbi.nlm.nih.gov/pubmed/24202340
http://dx.doi.org/10.3390/cancers5031177

Ejemplares similares